This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring both piperazine and pyrimidine moieties, makes it valuable for designing compounds targeting central nervous system disorders, particularly those involving neurotransmitter regulation. It is often employed in the creation of potential drug candidates for conditions like anxiety, depression, and schizophrenia due to its ability to interact with specific receptors in the brain. Additionally, its reactive amino group allows for further chemical modifications, enabling the development of diverse therapeutic agents. Researchers also explore its use in designing inhibitors for enzymes or proteins involved in disease pathways, contributing to advancements in medicinal chemistry.